子宫内膜癌中孤立肿瘤细胞、微转移和大转移的组织学特异性预后意义
这项回顾性研究利用美国国家癌症数据库2018至2021年87,904例I-III期子宫内膜癌患者,分析区域淋巴结转移大小和解剖位置与不同组织学类型总生存的关系。结果显示转移大小可能比解剖位置更具预后价值,孤立肿瘤细胞的预后意义因组织学类型而异,在低级别子宫内膜样癌中需进一步研究。
要点
- 相比盆腔微转移,无论盆腔或腹主动脉旁大转移均与总生存下降相关。
- 腹主动脉旁微转移与盆腔微转移的总生存相似。
- 低级别子宫内膜样癌中孤立肿瘤细胞与无淋巴结转移相比总生存下降,而在非子宫内膜样/高级别子宫内膜样癌中与无淋巴结转移相似。
核心结论
- 该队列研究结果提示,在子宫内膜癌中肿瘤转移大小可能比解剖位置更具预后价值。
- 孤立肿瘤细胞的组织学特异性交互作用值得进一步研究,尤其是在低级别子宫内膜样癌中。
研究设计与样本
- 回顾性研究,查询美国癌症委员会国家癌症数据库。
- 研究人群包括2018年至2021年的87,904例I-III期子宫内膜癌患者。
- 建立多变量Cox比例风险回归模型,按组织学类型(非子宫内膜样/高级别子宫内膜样或低级别子宫内膜样)评估总生存。
主要发现
- 在两种组织学组中,相比盆腔微转移,无论解剖位置(盆腔/腹主动脉旁)的大转移均与总生存下降相关:非子宫内膜样/高级别子宫内膜样组aHR 1.31(95%CI 1.08-1.59)/aHR 1.39(95%CI 1.13-1.72);低级别子宫内膜样组aHR 1.68(95%CI 1.19-2.36)/aHR 1.78(95%CI 1.10-2.88)。
- 腹主动脉旁微转移的总生存与盆腔微转移相似。
- 大转移的生存影响在低级别子宫内膜样癌中大于非子宫内膜样/高级别子宫内膜样癌(aHR范围1.68-1.78 vs 1.31-1.39)。
- 在非子宫内膜样/高级别子宫内膜样癌中,孤立肿瘤细胞相比盆腔微转移与更好的总生存相关(aHR 0.62,95%CI 0.45-0.85);孤立肿瘤细胞与无淋巴结转移的总生存相似(aHR 1.05,95%CI 0.80-1.38)。
- 相反,在低级别子宫内膜样癌中,孤立肿瘤细胞相比无淋巴结转移与总生存下降相关(aHR 1.55,95%CI 1.18-2.04);孤立肿瘤细胞与盆腔微转移的总生存相似(aHR 0.83,95%CI 0.56-1.24)。
关键数值与推荐
- 非子宫内膜样/高级别子宫内膜样癌:大转移(盆腔)aHR 1.31(95%CI 1.08-1.59);大转移(腹主动脉旁)aHR 1.39(95%CI 1.13-1.72)。
- 低级别子宫内膜样癌:大转移(盆腔)aHR 1.68(95%CI 1.19-2.36);大转移(腹主动脉旁)aHR 1.78(95%CI 1.10-2.88)。
- 非子宫内膜样/高级别子宫内膜样癌:孤立肿瘤细胞 vs 盆腔微转移aHR 0.62(95%CI 0.45-0.85);孤立肿瘤细胞 vs 无淋巴结转移aHR 1.05(95%CI 0.80-1.38)。
- 低级别子宫内膜样癌:孤立肿瘤细胞 vs 无淋巴结转移aHR 1.55(95%CI 1.18-2.04);孤立肿瘤细胞 vs 盆腔微转移aHR 0.83(95%CI 0.56-1.24)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the association between regional lymph node status based on metastatic size and anatomical location and survival per histology in endometrial cancer. METHODS: This retrospective study queried the Commission-on-Cancer's National Cancer Database. Study population included 87,904 patients with stage I-III endometrial cancer from 2018 to 2021. Multivariable Cox proportional hazard regression models were created to assess overall survival per histology (non-endometrioid / high-grade endometrioid or low-grade endometrioid). RESULTS: In both histology groups, comparing to pelvic micro-metastasis, macro-metastasis regardless of anatomical location (pelvic / para-aortic) was associated with decreased overall survival (non-endometrioid / high-grade endometrioid histology, adjusted-hazard ratio [aHR] 1.31, 95% confidence interval [CI] 1.08-1.59/aHR 1.39, 95%CI 1.13-1.72; and low-grade endometrioid histology, aHR 1.68, 95%CI 1.19-2.36 / aHR 1.78, 95%CI 1.10-2.88) while para-aortic micro-metastases had overall survival similar to pelvic micro-metastasis. Survival effects of macro-metastasis were larger in low-grade endometrioid compared to non-endometrioid / high-grade endometrioid histology (aHR range, 1.68-1.78 vs 1.31-1.39). For non-endometrioid / high-grade endometrioid histology, isolated tumor cells were associated with better overall survival compared to pelvic micro-metastasis (aHR 0.62, 95%CI 0.45-0.85); isolated tumor cells and negative nodal metastasis had similar overall survival (aHR 1.05, 95%CI 0.80-1.38). Contrary, in low-grade endometrioid histology, isolated tumor cells were associated with decreased overall survival compared to negative-node (aHR 1.55, 95%CI 1.18-2.04); isolated tumor cells had overall survival similar to pelvic micro-metastasis (aHR 0.83, 95%CI 0.56-1.24). CONCLUSION: The results of this cohort study suggest that tumor metastatic size may be more prognostic than anatomical location in endometrial cancer. Histology-specific interaction of isolated tumor cells warrants further investigation, especially in low-grade endometrioid histology.
引用
- Matsuo K, Agarwal J, Chen L, et al. Histology-specific prognostic significance of isolated tumor cells, micrometastases, and macrometastases in endometrial cancer. Gynecol Oncol. 2025. PMID: 39965448. doi:10.1016/j.ygyno.2025.02.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。